Ozempic’s Price ‘Very Likely’ To Be Subject Of Medicare Negotiations, Report Says
President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...
Klobuchar says courts should uphold law for Medicare drug price negotiations
Democratic lawmakers filed an amicus brief in an appeals case as the pharmaceutical industry fights a “pile-up” of losses in ...
Novo Nordisk shares sink on medicare price negotiation fears
Jared Holz, Mizuho, joins 'Fast Money' to talk how possible Medicare price negotiations are impacting Novo Nordisk shares.
STAT2d
Cassidy seeks to exempt small biotechs from Medicare drug price negotiation
WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...
Managed Healthcare Executive2d
Medicare’s Drug Price Negotiations Could Impact Physician Reimbursement
When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those ...
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
COMMENTARY: Stop the Biden-Harris raid on Medicare
The Inflation Reduction Act raids an estimated $260 billion in reduced Medicare drug spending to pay for unrelated spending.
pharmaphorum3d
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
The list for the next round of medicines that will be subject to Medicare price negotiations isn’t in yet, but the Institute for Clinical and Economic Review (ICER) reckons a chronic obstructive ...
Cortez Masto, Rosen join Amicus Brief for case to allow Medicare to negotiate on drug prices
U.S. Senators Catherine Cortez Masto and Jacky Rosen are joining other Democrats in filing an Amicus Brief in court case over whether Medicare can negotiate on drug prices ...